NA Proactive news snapshot: Royal Road Minerals, New Pacific Metals, Newgioco, Q BioMed UPDATE ...

Royal Road Minerals Limited (CVE:RYR),a gold and copper mineral exploration and development company, closed its previously announced million private placement. The company issued 13.6 million shares at a price of C$0.22 per share to Agnico Eagle Mines Limited for total proceeds of C$3 million. The company intends to use the proceeds for exploration operations in Colombia and Nicauraga and for general working capital purposes. Pollitt, the company’s agent in the deal, will receive cash equal to 6% of the gross proceeds and Royal Road will issue it warrants to buy shares equal to 6% of shares issued in the placement.

Canadian junior New Pacific Metals Corp (CVE:NUAG) (OTCMKTS:NUMPF) announced Wednesday that it turned a nearly C$1.9 million profit in its third quarter as the exploration and development company advances its Bolivian Silver Sands project. The figure is a sharp swing from the same period a year prior that saw the Vancouver-based company post a loss of C$753,000. New Pacific told shareholders that the results were mainly impacted by nearly C$2.1 million in income from investments.

Newgioco Group Inc (OTCMKTS:NWGI), a global sports betting and gaming technology company providing fully integrated software solutions to online and land-based gaming and sports betting operators, has appointed BDO AG based in Zurich, Switzerland as the company’s new independent registered public accounting firm. Pitagora Revisione had been the company’s auditor for the last three years. BDO’s selection comes as Newgioco plans to upgrade to he NASDAQ. 

Genprex Inc (NASDAQ:GNPX), a clinical-stage gene therapy company, announced a registered direct offering of 3,167,986 shares of its common stock at a price to the public of $0.40 per share, for proceeds of roughly $1.26 million. In a concurrent private placement, Genprex will issue investors in the registered direct offering unregistered warrants to purchase up to 3,167,986 shares. Joseph Gunnar & Co is the exclusive placement agent. The warrants will be exercisable six months from the issuance date, and have an exercise price of $0.46 per share, and will expire five years from such date. The warrants will be exercisable for shares of common stock purchased by investors in the registered direct offering. The closing of the offering is expected around November 25.

Capstone Turbine Corporation (NASDAQ:CPST), the maker of clean-energy microturbines, strengthened its board of directors with the appointment of former NRG Energy Inc (NYSE:NRG) executive Denise Wilson. Wilson served as executive vice president and president of new business at NRG, a Princeton-based Fortune 500 company with generation, energy retail business and cleantech ventures. 

Phunware Inc (NASDAQ:PHUN) has released an expansion to the sample code of its Location Based Services module, allowing for the implementation of new features using the company’s Location and Mapping Software Development Kits. The new sample code features include walk time calculations, which estimates the approximate walking time of a route and generates an estimated arrival time; voice prompts, which configures app to voice commands through a smartphone speaker or headphones; and off-route alerts, which prompt users when they go off course and prompt them to get back on track.

Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) announced the launch of an influencer-based product sales strategy for its Sollievo CBD line in southern California. The company is canvassing the more than 170 dispensaries in Los Angeles county, sending in sales agents armed with Sollievo product samples. Empower reps are also visiting smoke shops, vape stores and a variety of retail locations that carry CBD products or have expressed an interest in doing so.

Nextleaf Solutions Ltd (CSE:OILS) (OTCMKTS:OILFF) has been awarded two patents related to extraction of THC and CBD, bringing its total issued patents to ten. The company received a patent from the US Patent and Trademark Office, its sixth from the agency, pertaining to its proprietary chilled cannabinoid extraction process with downstream media treatment and filtration. The other patent came from the Superintendency of Industry and Commerce, the Colombian Government agency that administers intellectual property rights, covering Nexleaf’s industrial-scale process of extraction, refinement, and distillation of cannabinoids.

Exactus Inc (OTCQB:EXDI) and Canntab Therapeutics Limited (CSE:PILL) (OTCMKTS:CTABF) are teaming up to produce and sell immediate- and extended-release hemp-derived cannabinoid tablets. Canntab will manufacture its hard pill formulations (made from CBD and other hemp derivatives) in a Florida facility operated by Exactus, using equipment supplied by Canntab. Manufacturing is expected to begin near the end of first quarter of 2020. The hard-pill formulations will include a variety of hemp-derived cannabinoids for precise delivery in instant release, extended release and oral disintegrating tablet solutions to be distributed throughout the US. The agreement unlocks a distribution channel to an estimated at $2 billion-plus in the US CBD market. 

Q BioMed Inc (OTCMKTS:QBIO) announced Wednesday that the US Food and Drug Administration has cleared its contract manufacturer IsoTherapeutics Group LLC to produce the company’s non-opioid cancer bone pain drug Strontium-89 Chloride USP. The long-awaited approval of the facility means that this important oncologic pain drug will soon be available to patients in the US and the rest of the world, according to a statement. Q BioMed is now the only FDA-approved source for this drug in the western world. The company meanwhile is activating its planned commercial operations to support marketing, sales, and distribution in the US and, soon, in the rest of the world. Strontium-89 is a non-opioid radiopharmaceutical indicated for the treatment of painful skeletal metastases caused by cancer.

MegumaGold Corp (CSE:NSAU) reported encouraging initial soil survey results from its Touquoy West project in Nova Scotia, which lies around 4 km from St Barbara Ltd‘s (ASX:SBM) Touquoy gold mine in the Canadian province. A total of 1,062 samples were collected during September and October this year and submitted for gold and multi-element analysis, the company said in a statement. The work shows that two large geochemical anomalies are present, both of which are supported by low-level, anomalous gold and lie on what’s called the Moose River anticline which plays host to the Touquoy deposit.

Avalon GloboCare Corp. (NASDAQ:AVCO), a developer of cell-based technologies and therapeutics, will present at the upcoming 12th annual LD Micro Main Event institutional investor conference in Bel Air, California. CEO David Jin and CFO Luisa Ingargiola will give the company’s presentation at 2:20 pm PT (5:30 pm ET) on December 10, and the two will meet one-on-one with investors. The LD Micro Main Event is one of the biggest micro-cap conferences in the US, featuring 250 names presenting to more than 1,300 attendees. This year’s conference will be held December 10-12 at the Luxe Sunset Bel Air Hotel.

American Manganese Inc (CVE:AMY) (OTC:AMYZF) unveiled more high purity rates of nickel-cobalt hydroxide recovered from NCA cathode scrap material using its ground-breaking recycling technology.  On November 13 this year, the firm reported that its research contractor Kemetco had recovered 99.98% nickel-cobalt hydroxide from material it had received from a tier-one lithium-ion battery company referenced as ‘company B’.Today, the group reported on recovery rates from a battery company referenced as ‘company A’, which were an almost identical 99.977% nickel-cobalt hydroxide.

EnWave Corporation (TSXV:ENW) director Hugh McKinnon was appointed to the board of Vancouver-based business information company Glacier Media Inc. McKinnon has strong senior management leadership experience and expertise in strategy and operations.  McKinnon is also a member of the audit committee in EnWave which has advanced dehydration technology called Radiant Energy Vacuum (REV), which has wide application in the cannabis, food and pharmaceutical industries.

Diamond explorer Arctic Star Exploration Corp (CVE:ADD) (OTCMKTS:ASDZF) is set to bring in up to C$1.3 million gross through a private placing. The funds raised will be used for general working capital, to explore existing properties and potential future acquisitions, the company told investors. The firm will issue units at five Canadian cents each on a 1:5 post-consolidated basis, it said.  Each unit consists of one share and one share purchase warrant, with each whole warrant exercisable into one share for 15 Canadian cents for two years from closing.

Redfund Capital Corp announced Wednesday it had signed a letter of intent to acquire Florida-based Sunshine State Tea Company, part of an effort to develop CBD-infused tea brands. Redfund’s CEO Meris Kott told shareholders that the deal will give the investment company a path to its first direct revenue stream in the CBD-infused beverage market.
“We will continue to expand our reach into profitable revenue streams as the CBD market expands and is given more exposure promoting its health and wellness benefits,” Kott said in a statement.

Exactus Inc (OTCMKTS:EXDI) announced that it has entered into a supply and distribution agreement to provide Ceed2Med a minimum of 10,000 lbs of 2019 harvested flower. According to a statement, the hemp harvest will come from Exactus’ 200-acre farm in Southwest Oregon. Ceed2Med, in turn, will complete the conditioning, trimming and packaging of the product as per current wholesale market needs and distribute it to its clients at a higher profitability point, sharing Exactus in the upside of the operation.

Helix TCS Inc (OTCMKTS:HLIX), a technology group which provides the cannabis industry with a powerful operating services platform, said that it has launched the first integrated hemp tracking module. Its software subsidiary, BioTrackTHC already provides government cannabis tracking technology to 10 US states and territories. The Denver-based company said that now the hemp module for the BioTrackTHC Government Traceability system will allow the US state of Delaware to track all hemp and CBD products imported into the system, ensuring transparency and consumer safety. The system is live, allowing cannabis operators in Delaware to maintain auditable records of all hemp products in the supply chain, ensuring all products sold in the state are tested for potency and purity. 

Seelos Therapeutics Inc (NASDAQ:SEEL) said Wednesday that it has started dosing the first subjects in a Phase I drug-drug interaction (DDI) study to show that its SLS-002 intranasal ketamine depression drug can be safely administered with two commonly prescribed antidepressants. The study plans to enroll 48 healthy volunteers, studied over 14 days, randomized into two treatment arms and dosed with a combination of SLS-002 and either, venlafaxine ER or sertraline. “The initiation of the DDI study will be closely followed by an additional Phase I study measuring pharmacokinetic, pharmacodynamics, and safety of multiple, repeated, single doses of SLS-002 as well as IV ketamine,” said Seelos Therapeutics CEO Raj Mehra.

Story by ProactiveInvestors